Toggle navigation
Home
Search
Services
Blog
Contact
About
defibrotide for the treatment of severe hepatic veno-cc*
Richardson, Paul G.
Dana-Farber Cancer Institute, Boston, MA, United States
Search 19 grants from Paul Richardson
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Disease Persistence and Population Dynamics:Modeling Measles under Mass Vaccination
Ameliorating Crises in Persons with Sickle Cell Disease
Resource Support - Chem/Economic/Biol Information Needs
American Stop Smoking Intervention Study
Regional Medical Library Services
Recently added grants:
Prevention of Vein Graft Failure
Pulmonary Hypertension in Genetically Modified Mice
Deciphering the role of a novel micropeptide in cardiac function and dysfunction
Insulin Receptor Substrate Signaling in Pulmonary Hypertension
Signaling mechanisms and functions related to patho-physiology of vascular, lung and blood systems
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Research Project (R01)
Project #
5R01FD002548-02
Application #
7129051
Study Section
Special Emphasis Panel (ZFD1-SRC (99))
Program Officer
Ganti, Usha
Project Start
2004-09-01
Project End
2009-08-31
Budget Start
2007-09-01
Budget End
2009-08-31
Support Year
2
Fiscal Year
2007
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Related projects
NIH 2007
R01 FD
defibrotide for the treatment of severe hepatic veno-cc*
Richardson, Paul G. / Dana-Farber Cancer Institute
NIH 2005
R01 FD
Defibrotide for the treatment of severe hepatic veno-cc*
Richardson, Paul G. / Dana-Farber Cancer Institute
Comments
Be the first to comment on Paul Richardson's grant